Looking to balance out your exposure to IBIO? The ETFs below have historically moved differently from IBIO, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.
Best Diversifiers for IBIO
1 ETFs have low correlation with IBIO (below 0.3), 0 of which are negatively correlated. The least correlated is Schwab U.S. Dividend Equity ETF (SCHD) (Dividend) with a 1Y correlation of 0.06, roughly unchanged from 0.15 over 5 years.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| Schwab U.S. Dividend Equity ETF | 0.06 | 0.10 | 0.15 | 94 | Dividend | IBIO vs SCHD | |
| SPDR S&P Biotech ETF | 0.39 | 0.29 | 0.34 | 93 | Health & Biotech Equities | IBIO vs XBI |
Low-Correlation Stock Ideas
The table shows companies with at least $1B in market capitalization, historical correlation data for IBIO, and a Risk / Return Rank of 50 or higher. Treat them as research candidates rather than evidence that they will offset a future decline. The least correlated is Pfizer Inc. (PFE) (Healthcare) with a 1Y correlation of 0.12, roughly unchanged from 0.10 over 5 years.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Sector |
|---|---|---|---|---|---|---|
| Pfizer Inc. | 0.12 | 0.15 | 0.10 | 58 | Healthcare |
Build a portfolio that complements IBIO
Add IBIO to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with IBIO